BOCA RATON, Fla., ZGSI — Zero Gravity Solutions, Inc. (“ZGSI or the “Company’), trading symbol PK:ZGSI.PK (Pink Sheets:ZGSI) announced today that it has completed the filings required to satisfy the financial reporting necessary to commence the trading of the Company’s stock under the trading symbol ZGSI.PK.
Zero Gravity Solutions, Inc., a zero gravity biotechnology company, is at the forefront of utilizing the unique effects of extended zero/micro gravity environments only available on the International Space Station (“ISS”), now a national lab. The Company’s intellectual property was developed and validated through six NASA-enabled flights to the ISS under the Company’s Space Act Agreement. ZGSI’s intellectual property is based upon the premise that genes and cells express differently in a zero/microgravity environment, allowing for the development of patentable plant, animal and human regenerative stem cells with unique and beneficial characteristics.
The Company has assembled a highly knowledgeable and experienced group of business and financial professionals as well as well-known and respected scientific leaders in applied research relating to ZGSI’s core commercialization opportunities. The work of these scientific leaders has an emphasis on the effects of zero/micro gravity on cash crops, alternative energy cash crops and human regenerative medicine.
Mr. Richard Godwin, Zero Gravity Solutions, Inc.’s president and chief executive officer stated, “Based upon my 20 years of involvement in various aspects of the US space program, it is clear to me that a central focus of NASA and CASIS today is to accelerate the commercial use of the International Space Station. We believe the Company can earn money by performing applied research that can only be done on the ISS: Exposing stem cells to extended microgravity to promote gene expression that can result in new varieties of stem cells with commercial applications.” Mr. Godwin further stated, “Our business model for Zero Gravity Solutions is to ultimately patent and license these non-GMO stem cells for commercial use which can produce royalty revenue that represents a recurring revenue stream.”
About Zero Gravity Solutions, Inc.
Zero Gravity Solutions, Inc. is a zero gravity biotechnology company whose mission is to commercialize, industrialize and monetize the unique capabilities of the ISS platform and low earth orbit. The Company is developing advances in plant, animal and human biology based on intellectual property derived from multiple experiments on the International Space Station. The Company owns Intellectual Property that is aimed at developing and producing in a microgravity environment, large volumes of novel stem cells with unique and beneficial characteristics, without Genetic Modification techniques, which can then be patented for commercial sale to third parties in the agricultural and medical markets. ZGSI is headquartered in Boca Raton, Florida and has offices and/or operations Naperville, Illinois, Stevensville, Maryland. Information on the Company can be viewed on www.zerogsi.com
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.